Abeona Therapeutics, Inc. (ABEO)
5.85
-0.07
(-1.18%)
USD |
NASDAQ |
Aug 31, 16:00
5.86
+0.01
(+0.17%)
After-Hours: 20:00
Abeona Therapeutics Cash from Operations (TTM) : -76.44M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -76.44M |
| March 31, 2026 | -77.73M |
| December 31, 2025 | -76.33M |
| September 30, 2025 | -74.93M |
| June 30, 2025 | -65.98M |
| March 31, 2025 | -59.88M |
| December 31, 2024 | -56.02M |
| September 30, 2024 | -48.84M |
| June 30, 2024 | -42.35M |
| March 31, 2024 | -39.95M |
| December 31, 2023 | -37.16M |
| September 30, 2023 | -41.77M |
| June 30, 2023 | -42.81M |
| March 31, 2023 | -41.54M |
| December 31, 2022 | -43.48M |
| September 30, 2022 | -59.75M |
| June 30, 2022 | -63.29M |
| March 31, 2022 | -65.77M |
| December 31, 2021 | -65.66M |
| September 30, 2021 | -37.02M |
| June 30, 2021 | -37.39M |
| March 31, 2021 | -35.37M |
| December 31, 2020 | -35.02M |
| September 30, 2020 | -47.66M |
| June 30, 2020 | -55.21M |
| Date | Value |
|---|---|
| March 31, 2020 | -60.97M |
| December 31, 2019 | -62.82M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -27.47M |
| June 30, 2018 | -25.20M |
| March 31, 2018 | -21.16M |
| December 31, 2017 | -22.94M |
| September 30, 2017 | -21.00M |
| June 30, 2017 | -18.22M |
| March 31, 2017 | -16.36M |
| December 31, 2016 | -13.01M |
| September 30, 2016 | -12.50M |
| June 30, 2016 | -11.02M |
| March 31, 2016 | -9.776M |
| December 31, 2015 | -10.42M |
| September 30, 2015 | -8.648M |
| June 30, 2015 | -6.276M |
| March 31, 2015 | -4.649M |
| December 31, 2014 | -1.611M |
| September 30, 2014 | -0.983M |
| June 30, 2014 | -1.759M |
| March 31, 2014 | 0.222M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Forum Markets, Inc. | -56.96M |
| Corcept Therapeutics, Inc. | 109.70M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |